Literature DB >> 32057862

Protective effect of Polygonatum sibiricum polysaccharides on gentamicin-induced acute kidney injury in rats via inhibiting p38 MAPK/ATF2 pathway.

Chunyang Han1, Taotao Sun1, Yawei Liu1, Guangtai Fan1, Wanjun Zhang1, Cuiyan Liu2.   

Abstract

The aim of this study was to investigate the protective effect of Polygonatum sibiricum polysaccharides (PSP) on acute kidney injury (AKI) in rats. The AKI model was established with 100 mg/kg of gentamicin (GM) intramuscularly. Six hours post-injection, rats were given intragastrically different dosages of PSP (0.25, 0.5, and 1 g/kg) for seven consecutive days. Results showed that compared with the model group, the kidney coefficient of rats decreased significantly (P < 0.05), and rat serum CRE and urea levels were significantly decreased (P < 0.05) in the PSP treatment group. The expression of NGAL, KIM-1, IL-1β, IL-6, TNF-α, and p38 MAPK mRNA in the kidney were significantly decreased (P < 0.05). The protein expression of p38 MAPK, p-p38 MAPK, and p-ATF2 were decreased to different degrees. Among the three-PSP treatment groups, the medium-dose group displayed the most protective effects. In conclusion, PSP had a powerful protective effect on GM-induced AKI in rats, it decreased the expression of NGAL or KIM-1 mRNA in kidney tissue and inhibited the p38 MAPK/ATF2 signaling pathway and the production of inflammatory factors TNF-α, IL-1β, and IL-6.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Gentamicin; Polygonatum sibircum polysaccharides; Rat; p38 MAPK/ATF2 pathway

Mesh:

Substances:

Year:  2020        PMID: 32057862     DOI: 10.1016/j.ijbiomac.2020.02.049

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK/ATF2 signaling pathways.

Authors:  Sung-Min Kim; Eun-Jung Park; Hae-Jeung Lee
Journal:  Inflammopharmacology       Date:  2022-10-11       Impact factor: 5.093

2.  Synergistic Effect of Polydatin and Polygonatum sibiricum Polysaccharides in Combating Atherosclerosis via Suppressing TLR4-Mediated NF-κB Activation in ApoE-Deficient Mice.

Authors:  Genyi Ye; Yuhao Zhao; Junfeng Zhu; Zijian Zhang; Qiong Wang; Xu Jiang; Zhenxing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

Review 3.  Polysaccharides from Medicine and Food Homology Materials: A Review on Their Extraction, Purification, Structure, and Biological Activities.

Authors:  Jiaqi Xu; Jinling Zhang; Yumei Sang; Yaning Wei; Xingyue Chen; Yuanxin Wang; Hongkun Xue
Journal:  Molecules       Date:  2022-05-17       Impact factor: 4.927

4.  Network pharmacology and experimental investigation of Rhizoma polygonati extract targeted kinase with herbzyme activity for potent drug delivery.

Authors:  Yingqiu Xie; Chengling Mu; Bexultan Kazybay; Qinglei Sun; Aidana Kutzhanova; Guldan Nazarbek; Na Xu; Lazzat Nurtay; Qian Wang; Amr Amin; Xugang Li
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 5.  Advances in Mechanism Research on Polygonatum in Prevention and Treatment of Diabetes.

Authors:  Shuang Liu; Qiao-Jun Jia; Yi-Qing Peng; Ting-Hui Feng; Shu-Ting Hu; Juan-E Dong; Zong-Suo Liang
Journal:  Front Pharmacol       Date:  2022-02-08       Impact factor: 5.810

6.  Polygonatum sibiricum Polysaccharides Attenuate Lipopoly-Saccharide-Induced Septic Liver Injury by Suppression of Pyroptosis via NLRP3/GSDMD Signals.

Authors:  Linxia Xiao; Liang Qi; Guozhe Zhang; Hongxia Liu; Yaqin Gu; Lihu Zhang; Mingguang Zhang; Hongyan Wu
Journal:  Molecules       Date:  2022-09-15       Impact factor: 4.927

7.  Mechanochemical prepared ibuprofen-Polygonatum sibiricum polysaccharide drug delivery system for enhanced bioactivity with reduced renal injury induced by NSAIDs.

Authors:  Wenhao Xu; Jinli Yang; Xiangyang Gu; Wenjing Su; Faxiang Pu; Zhangfu Xie; Kongliang Jin; Weike Su; Lichan Mao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.